Amgen Inc (AMGN)
319.22
-0.94
(-0.29%)
USD |
NASDAQ |
Nov 01, 16:00
317.56
-1.66
(-0.52%)
After-Hours: 20:00
Amgen Market Cap: 171.59B for Nov. 1, 2024
Market Cap Chart
Historical Market Cap Data
| Date | Value |
|---|---|
| November 01, 2024 | 171.59B |
| October 31, 2024 | 172.10B |
| October 30, 2024 | 169.61B |
| October 29, 2024 | 169.86B |
| October 28, 2024 | 170.49B |
| October 25, 2024 | 170.39B |
| October 24, 2024 | 169.68B |
| October 23, 2024 | 169.26B |
| October 22, 2024 | 171.82B |
| October 21, 2024 | 170.25B |
| October 18, 2024 | 172.89B |
| October 17, 2024 | 172.71B |
| October 16, 2024 | 172.88B |
| October 15, 2024 | 174.74B |
| October 14, 2024 | 174.48B |
| October 11, 2024 | 176.49B |
| October 10, 2024 | 172.54B |
| October 09, 2024 | 173.30B |
| October 08, 2024 | 170.75B |
| October 07, 2024 | 170.63B |
| October 04, 2024 | 171.82B |
| October 03, 2024 | 170.65B |
| October 02, 2024 | 171.85B |
| October 01, 2024 | 172.17B |
| September 30, 2024 | 173.19B |
| Date | Value |
|---|---|
| September 27, 2024 | 173.38B |
| September 26, 2024 | 171.46B |
| September 25, 2024 | 168.11B |
| September 24, 2024 | 177.81B |
| September 23, 2024 | 180.33B |
| September 20, 2024 | 181.28B |
| September 19, 2024 | 180.52B |
| September 18, 2024 | 178.89B |
| September 17, 2024 | 178.82B |
| September 16, 2024 | 180.14B |
| September 13, 2024 | 178.64B |
| September 12, 2024 | 177.35B |
| September 11, 2024 | 177.31B |
| September 10, 2024 | 176.74B |
| September 09, 2024 | 175.13B |
| September 06, 2024 | 172.25B |
| September 05, 2024 | 174.29B |
| September 04, 2024 | 177.66B |
| September 03, 2024 | 177.59B |
| August 30, 2024 | 179.38B |
| August 29, 2024 | 177.86B |
| August 28, 2024 | 177.04B |
| August 27, 2024 | 175.67B |
| August 26, 2024 | 175.59B |
| August 23, 2024 | 176.67B |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
107.49B
Minimum
Mar 12 2020
181.28B
Maximum
Sep 20 2024
138.82B
Average
136.99B
Median
Market Cap Benchmarks
| Johnson & Johnson | 385.53B |
| Eli Lilly and Co | 777.42B |
| Merck & Co Inc | 258.25B |
| Regeneron Pharmaceuticals Inc | 92.70B |
| Viking Therapeutics Inc | 8.121B |
Market Cap Related Metrics
| PE Ratio | 40.87 |
| PS Ratio | 5.291 |
| Price to Book Value | 22.80 |
| Price to Free Cash Flow | 27.40 |
| Price | 319.22 |
| Earnings Yield | 2.45% |
| Operating PE Ratio | 27.68 |
| Normalized PE Ratio | 40.87 |